San Francisco Biotech Networks

SFBN Feed: Exicure, Inc. Reports Second Quarter 2025 Financial Results https://lnkd.in/gQ_8gtD5 REDWOOD CITY, Calif.–(BUSINESS WIRE)–Exicure, Inc. Reports Second Quarter 2025 Financial Results Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: xCures Achieves Fully Functional IAS Solution https://lnkd.in/gnSGTfxV The fully operational Individual Access Services (IAS) solution under TEFCA will deliver on the promise of truly connected healthcare by giving patients and providers seamless, secure access to medical records across the nation. OAKLAND, Calif., [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: DentScribe CoPilot Is Changing the Game for Mom-Dentists: SOAP Notes Now Fuel Profit, Not Burden https://lnkd.in/gScngAnp SUNNYVALE, Calif., Aug. 8, 2025 /PRNewswire/ — For busy mom-dentists, charting SOAP notes used to mean after-hours toil and mental drain. That’s changed entirely for Dr. Kristina Zoulas, founder of Berkeley Dental Studio and member [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

📧 According to the Litmus 2025 State of E-mail report (link below), e-mail marketing achieves an amazing ROI of 10:1 to 36:1! Check out Biotech Networks upcoming e-mail blast openings below and at https://lnkd.in/gk-NYTni and email info@biotechnetworks.org to secure your spot. Litmus 2025 State of Email Report: https://lnkd.in/dcaA4xTB

SFBN Feed: Gilead culls Novo-partnered MASH candidate and 2 cancer assets https://lnkd.in/gHRE3-ie After the recent approval and launch of twice-yearly HIV prophylactic Yeztugo, Gilead is cleaning up its R&D pipeline. The Bay Area company has dropped two early-stage cancer candidates and a Novo Nordisk-partnered combination treatment for [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Amid excitement over Yeztugo, Gilead sees continued erosion of CAR-T sales https://lnkd.in/g6i3E8Ue While most of Gilead’s second-quarter presentation focused on its excitement over the launch of game-changing HIV PrEP drug Yeztugo, there was a disquieting sidebar as sales of its cell therapies were down by 7%. Click [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Gilead cuts several mid-stage and early-stage programs https://lnkd.in/gu2St5ZF Gilead made a series of pipeline cuts in the second quarter, including a Phase 2 RSV program and a Novo Nordisk-partnered semaglutide regimen for a debilitating liver disease. Its RSV candidate, obeldesivir, was pulled from [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Sutter Health eyes 2028 opening of $442 million neuroscience center https://lnkd.in/gUfU8_uR Among other things, the 129,000-square-foot structure will incorporate the Ray Dolby Brain Health Center and the Forbes Norris MDA/ALS Research and Treatment Center. Click here to view original post Click Here to Publish/Feature Your Company [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Sutter Health opens Livermore Care Center, part of community-focused expansion https://lnkd.in/grgUJGSF Sutter Health’s Livermore Care Center opened in June. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Bicycle Therapeutics lays off staff, Genentech partnership comes to an end https://lnkd.in/gbe5GEss Bicycle Therapeutics disclosed that it is laying off 25% of its employees as part of a larger cost-cutting effort. It also said that its partnership with Roche’s subsidiary Genentech was coming to an end after [...] #BayArea #SanFrancisco #Biotech #Lifescience #News